An Ocular Implant From the Borg

In this brief two‑speaker discussion, Speaker A introduces Prima, an ocular brain‑computer interface (BCI) developed by entrepreneur Max Hodak—formerly president of Neuralink—that has received European regulatory approval to treat age‑related macular degeneration (AMD). The device is implanted behind the retina; it converts visual information into electrical stimulation of the remaining retinal cells, which then relay signals through the optic nerve to the visual cortex, effectively restoring central vision. Clinical data show an average gain of five lines on a standard eye chart after twelve months of use. Speaker B frames the technology in sci‑fi terms, likening it to a Borg ocular implant, and argues that approaches avoiding direct brain electrode placement are more scalable toward mass‑market consumer devices. The conversation highlights the intersection of cutting‑edge neurotechnology, regulatory milestones, and future market considerations.










